A medical affairs team in Latin America held an HCP advisory board to get expert feedback on several key issues related to a specific drug used to treat a chronic condition.
The team established the following objectives:
- Gather feedback on therapies that reduce the risk of comorbidities in patients with the chronic condition
- Obtain perceptions of the safety and efficacy of the drug pertaining to comorbidities
- Evaluate HCP-targeted messaging for the drug